🇮🇱 Israel Country × Condition
plasma cell myeloma refractory Clinical Trials in Israel
Active clinical trials for plasma cell myeloma refractory with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 1 // Recruiting: 1 Phases: Phase 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇮🇱 Israel
Active Trials in Israel (1)
Frequently Asked Questions
How many plasma cell myeloma refractory clinical trials are active in Israel?
There are currently 1 active clinical trials for plasma cell myeloma refractory with sites in Israel, of which 1 are actively recruiting patients.
How can I join a plasma cell myeloma refractory clinical trial in Israel?
To join a plasma cell myeloma refractory clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are plasma cell myeloma refractory trials in Israel?
Active plasma cell myeloma refractory trials in Israel span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology